TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Return
21.62%
This Quarter Return
-3.24%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$709M
AUM Growth
+$29.4M
(+4.3%)
Cap. Flow
+$74.6M
Cap. Flow
% of AUM
10.53%
Top 10 Holdings %
Top 10 Hldgs %
39.27%
Holding
116
New
17
Increased
23
Reduced
16
Closed
10
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$22.4M |
| 2 |
Intellia Therapeutics
NTLA
|
$12.6M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$10.3M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$7.6M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
$6.42M |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$9.42M |
| 2 |
Capital One
COF
|
$8.75M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$4.6M |
| 4 |
Pyxis Oncology
PYXS
|
$4.58M |
| 5 |
Phathom Pharmaceuticals
PHAT
|
$3.58M |
Sector Composition
| 1 | Healthcare | 94.04% |
| 2 | Financials | 5.11% |
| 3 | Real Estate | 0.78% |
| 4 | Consumer Discretionary | 0.07% |
| 5 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Adicet Bio
ACET
$58.1M
| $1.68M | 0.24% |
1,226,352
-1,253,200
| -51% | -$1.72M |
|
77
Journey Medical
DERM
$184M
| $1.58M | 0.22% |
+576,100
| New | +$1.58M |
|
78
Arvinas
ARVN
$557M
| $1.57M | 0.22% |
80,000
| – | – |
|
79
ServisFirst Bancshares
SFBS
$4.8B
| $1.57M | 0.22% |
30,000
| – | – |
|
80
Editas Medicine
EDIT
$218M
| $1.56M | 0.22% |
200,000
| – | – |
|
81
ARS Pharmaceuticals
SPRY
$1.05B
| $1.55M | 0.22% |
409,463
| – | – |
|
82
Nkarta
NKTX
$145M
| $1.53M | 0.22% |
1,103,638
-282,191
| -20% | -$392K |
|
83
Coherus Oncology, Inc. Common Stock
CHRS
$153M
| $1.5M | 0.21% |
400,000
| – | – |
|
84
Bank of Hawaii
BOH
$2.71B
| $1.49M | 0.21% |
30,000
| – | – |
|
85
Fate Therapeutics
FATE
$111M
| $1.48M | 0.21% |
700,000
| – | – |
|
86
Black Diamond Therapeutics
BDTX
$159M
| $1.15M | 0.16% |
+400,000
| New | +$1.15M |
|
87
Ascendis Pharma
ASND
$12.2B
| $936K | 0.13% |
10,000
| – | – |
|
88
TG Therapeutics
TGTX
$4.93B
| $836K | 0.12% |
+100,000
| New | +$836K |
|
|
ATYR
89
aTyr Pharma
ATYR
$521M
| $744K | 0.11% |
471,134
+321,134
| +214% | +$507K |
|
90
Athira Pharma
ATHA
$15.2M
| $712K | 0.1% |
352,715
| – | – |
|
91
Gossamer Bio
GOSS
$578M
| $698K | 0.1% |
+838,600
| New | +$698K |
|
92
908 Devices
MASS
$193M
| $666K | 0.09% |
100,000
| – | – |
|
93
Invivyd
IVVD
$209M
| $623K | 0.09% |
366,536
-785,307
| -68% | -$1.34M |
|
94
Inspirato
ISPO
$36.2M
| $517K | 0.07% |
43,779
-7,971
| -15% | -$94.1K |
|
95
NextCure
NXTC
$13.3M
| $516K | 0.07% |
33,333
| – | – |
|
|
GRCL
96
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $458K | 0.06% |
+159,087
| New | +$458K |
|
97
Stellar Bancorp
STEL
$1.59B
| $426K | 0.06% |
20,000
| – | – |
|
98
Cartesian Therapeutics
RNAC
$258M
| $424K | 0.06% |
13,333
| – | – |
|
|
MOLN
99
Molecular Partners
MOLN
$144M
| $414K | 0.06% |
100,000
+60,247
| +152% | +$249K |
|
100
Equillium
EQ
$62.9M
| $296K | 0.04% |
400,000
| – | – |
|